DEF 14A
DEF 14A Filing
- Company
- Matinas BioPharma Holdings, Inc.
- Filed
- October 1, 2020
- Period of Report
- October 1, 2020
- Accession Number
- 0001641172-20-000014
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →